STRS Ohio’s Immunovant IMVT Stock Holding History

STRS Ohio’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.26M	Buy	+32,800	New	+$999K	﹤0.01%	645
2025 Q2	–	Sell	-1,600	Closed	-$27.3K	–	2249
2025 Q1	$27.3K	Hold	1,600	–	–	﹤0.01%	1828
2024 Q4	$39.6K	Sell	1,600 -2,400	-60%	-$68.1K	﹤0.01%	1753
2024 Q3	$114K	Sell	4,000 -13,500	-77%	-$398K	﹤0.01%	1683
2024 Q2	$462K	Buy	17,500 +1,800	+11%	+$51.2K	﹤0.01%	1294
2024 Q1	$507K	Sell	15,700 -2,500	-14%	-$91.2K	﹤0.01%	1251
2023 Q4	$766K	Sell	18,200 -15,500	-46%	-$570K	﹤0.01%	1013
2023 Q3	$1.29M	Sell	33,700 -2,400	-7%	-$54.2K	0.01%	795
2023 Q2	$684K	Sell	36,100 -1,700	-4%	-$31.7K	﹤0.01%	1104
2023 Q1	$586K	Buy	37,800 +1,800	+5%	+$31.2K	﹤0.01%	1205
2022 Q4	$639K	Buy	36,000 +8,900	+33%	+$112K	﹤0.01%	1162
2022 Q3	$151K	Hold	27,100	–	–	﹤0.01%	1677
2022 Q2	$105K	Hold	27,100	–	–	﹤0.01%	1760
2022 Q1	$149K	Hold	27,100	–	–	﹤0.01%	1770
2021 Q4	$230K	Buy	27,100 +18,900	+230%	+$156K	﹤0.01%	1698
2021 Q3	$71K	Buy	+8,200	New	+$74K	﹤0.01%	1999
2021 Q1	–	Sell	-9,100	Closed	-$420K	–	2222
2020 Q4	$420K	Buy	9,100 +400	+5%	+$18.5K	﹤0.01%	1545
2020 Q3	$306K	Buy	8,700 +3,800	+78%	+$114K	﹤0.01%	1559
2020 Q2	$119K	Buy	+4,900	New	+$105K	﹤0.01%	1753

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

STRS Ohio's IMVT Position: Q2 2026 in Review

STRS Ohio opened a new position in Immunovant (IMVT) in Q2 2026: 32,800 shares worth $1.26M. The stake represents ﹤0.01% of the portfolio and ranks #645 among its holdings. This is a return to the name: STRS Ohio previously reported a position in IMVT as recently as Q1 2025.

STRS Ohio first reported a position in IMVT in Q2 2020 and has held it in 19 quarters since. The position peaked at $1.29M in Q3 2023. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

STRS Ohio held 32,800 shares of Immunovant worth $1.26M as of Q2 2026.
Immunovant was a new STRS Ohio position in Q2 2026.
Immunovant made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #645 holding.
STRS Ohio first reported a position in Immunovant in Q2 2020 and has held it in 19 quarters since.
STRS Ohio's Immunovant position peaked at $1.29M in Q3 2023.
227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.